Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nuclear receptor coactivators

S Westin1, M G Rosenfeld, C K Glass

  • 1Department of Medicine, University of California, San Diego, La Jolla 92093-0651, USA.

Advances in Pharmacology (San Diego, Calif.)
|December 3, 1999
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prenatal β-catenin/Brn2/Tbr2 transcriptional cascade regulates adult social and stereotypic behaviors.

Molecular psychiatry·2016
Same author

A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours.

British journal of cancer·2014
Same author

Effect of natural genetic variation on enhancer selection and function.

Nature·2013
Same author

The role and mechanism of growth hormone in the regulation of sexually dimorphic P450 enzymes in rat liver.

The Journal of steroid biochemistry and molecular biology·2012
Same author

PI3K/AKT signaling determines a dynamic switch between distinct KSRP functions favoring skeletal myogenesis.

Cell death and differentiation·2011
Same author

Macrophage scavenger receptors and atherosclerosis.

Trends in cardiovascular medicine·2011
Same journal

Preface.

Advances in pharmacology (San Diego, Calif.)·2026
Same journal

T Cell subsets for therapy-unconventional CD1d-restricted natural killer T cells.

Advances in pharmacology (San Diego, Calif.)·2026
Same journal

Tracking therapeutic T cells in vivo.

Advances in pharmacology (San Diego, Calif.)·2026
Same journal

In vivo transduction of CAR T cells: Pharmacological principles, delivery platforms, and the road to clinical translation.

Advances in pharmacology (San Diego, Calif.)·2026
Same journal

Transient T cell therapies.

Advances in pharmacology (San Diego, Calif.)·2026
Same journal

Manufacturing as biology: How T-cell processing shapes therapeutic outcomes.

Advances in pharmacology (San Diego, Calif.)·2026
See all related articles